UNC’s Norman Sharpless Named NCI Director; Senators Back to Work on Healthcare Bill; National Institutes of Health Director to Remain
On June 12, 2017, President Trump named Norman Sharpless, MD, as director of National Cancer Institute (NCI). Sharpless, formerly the director of the Lineberger Comprehensive Cancer Center at the University of North Carolina, is a practicing oncologist and cancer researcher. He will take over as for Doug Lowry, MD, who has been the NCI’s acting director since 2015.
Presidential Personnel Appointments That Affect Healthcare Policy
There is a difference between campaigning and governing. Running for office is about putting out bold ideas and galvanizing a base of supporters who are energized by the opportunity for real change. It’s exhilarating and fluid. The momentum can be like a rock concert, and people are carried away with excitement about the future.
Serving on Boards Allows Nurses to Improve the Nation’s Health
As the largest healthcare profession and the one most trusted by the public in the annual Gallup survey, nurses have the power to improve the health of communities throughout the country by bringing their expertise into the boardroom. However, we are an absent voice in so many of those boardrooms.
Cancer Death Rates Continue to Fall; Biden Continues Work on Cancer Moonshot; GOP Looks to Revise Replacement Healthcare Plan; ONS Submits Letter of Support for New ICD-10 CM Code
The National Institutes of Health (NIH) recently released the Annual Report to the Nation on the Status of Cancer, 1975–2014. According to the report, cancer death rates fell for 11 of the 16 most common cancers in men and 13 of the 16 most common cancers in women. Death rates fell for female breast cancer, lung cancer, colorectal cancer, and prostate cancers, among others. The report also notes that incidences of cancer decreased in men but plateaued for women in the same time period.
Trump Budget Proposal Cuts Healthcare Spending, Research; GOP’s Healthcare Bill Faces Stiff Resistance
On March 15, 2017, the Trump administration released its first budget proposal, slashing federal spending in many areas of health care, education, environmental protection, and the sciences while increasing funding for defense and homeland security. The proposed budget would decrease spending for the Department of Health and Human Services by nearly 18%, which includes a 20% budget cut for the National Institutes of Health (NIH)—a decrease of nearly $6 billion. This stands to impact a number of cancer-related research programs developing new treatments and drugs through NIH funding.
GOP Announces Healthcare Replacement Plan; CMS Nominee Confirmed; Secretary Price Discusses Repeal, Replace
On March 8, 2017, House Speaker Paul Ryan announced the American Health Care Act (AHCA), the Republican replacement plan for the Affordable Care Act (ACA). The AHCA is becoming known to many on Capitol Hill as Trumpcare, and it’s already facing stiff opposition from Democrats and Republicans alike. Many conservative Republicans are calling it Obamacare 2.0 and expected a full repeal of the ACA. Moderate Republicans are unlikely to support the bill, because it could potentially strand millions without insurance coverage provided by the ACA.
Concern Over ACA Repeal, Bipartisan Support Against Opioid Epidemic, ACA Replacement May Mean Unwanted Limitations
In a series of articles published by the Washington Post, patients living with cancer are speaking out against the potential harm that could impact cancer care with repeal of the Affordable Care Act (ACA). Told through each patient’s own experience with the ACA, the stories paint a vivid picture for lawmakers on Capitol Hill. By putting a face to those affected by repealing the ACA, this series may give representatives pause before they consider getting rid of the healthcare bill.
Opportunities Exist for Health Policy Compromise in 2017
The 115th U.S. Congress was sworn into office on January 3, 2017. Capitol Hill was abuzz with congratulatory smiles, wide-eyed optimism, and not a small amount of relief for those who survived last November’s election.
Now Is an Exciting Time for Advocacy
The Important Health Policy Issues Oncology Nurses Should Know for the 2016 Presidential Election
New Law and Policies Will Fight Opioid Epidemic
National Quality Forum Seeks Comments for Quality Measures
The National Quality Forum (NQF) Cancer Project 2015–2017 seeks to identify and endorse performance measures for accountability reporting and quality improvement that specifically address conditions, treatments, interventions, or procedures relating to cancer. A detailed overview of the goals/objectives of the Cancer Project is provided by NQF.
ONS Member Speaks to U.S. Congress at OVAC Advocacy Day
Legislation Passed to Combat Opioid Abuse; ONS Chapter Advocates in DC; ONS, CMS, Others Discuss Medicare Changes
Becoming a Nursing Advocate in Washington, DC
Capitol Hill Roundup: FDA Releases Draft Guidelines for Biosimilars; Cancer Moonshot Launches Online Engagement Platform; PQLC's Virtual Lobby Day
ONS Joins OVAC Advocacy Day to Share the Role of Oncology Nurses in Cancer Care
President Addresses Precision Medicine at White House Summit
“You can match a blood transfusion to a blood type...what if matching a cancer cure to our genetic code was just as easy, just as standard? What if figuring out the right dose of medicine was as simple as taking our temperature?”